Astrazeneca shot shows no increased clot risk after two doses

Blot clots are not more likely after second Astrazeneca jab, data published in The Lancet suggests.
Photo: Athit Perawongmetha/REUTERS / X02943
Photo: Athit Perawongmetha/REUTERS / X02943
By Deirdre Hipwell and Suzi Ring, Bloomberg

Astrazeneca's covid-19 vaccine doesn't raise the risk of a rare blood clotting disorder after a second dose, suggesting people shouldn't hesitate to get another one if they didn't have trouble after the first.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading